WHAT THIS PAPER ADDS This is the largest series presented to date of use of self-expanding stents (SES) in the chimney graft (CG) technique for endovascular repair (EVAR) of juxtarenal aortic aneurysms (JRAA). The so-called Open Chimney (OCh) EVAR has the advantages of reducing complexity, manufacturing time, and costs of fenestrated EVAR in selected JRAA. Moreover, compared with covered stents, use of SES in the GG technique allows a size reduction in the sheath introducer from the left brachial access, possibly decreasing cerebrovascular complications and also permits improved blood flow to the stented renal artery, possibly giving an advantage in the target vessel long-term patency.
INTRODUCTION
The lack of a suitable proximal neck is the most common factor precluding standard endovascular repair (EVAR) in abdominal aortic aneurysms (AAA). A proximal landing zone (LZ) shorter than 10 mm is a contraindication for all endovascular grafts currently available "off-the-shelf". Distinct from infrarenal AAAs, juxtarenal aortic aneurysms (JRAAs) carry greater morbidity and mortality rates with open surgery.
1,2 A minimally invasive approach should be advocated in patients at high physiological risk. 3 Technology is now available for fenestrated (F)-EVAR devices to obtain an adequate sealing above the orifices of renal or mesenteric arteries. 4, 5 However, F-EVAR requires extensive experience in standard EVAR, renal vessel catheterisation as well as stent delivery and shaping, experience which can only be obtained in referral centres specialising in complex aortic treatment.
The need for "off-the-shelf" endovascular grafts and simplification of the suprarenal sealing zone technique has led to the development of a different "off-label" approach to the endovascular treatment of JRAA called the "snorkel" or "chimney" graft (CG) technique. First described by Greenberg et al., 6 the CG technique consists of the delivery of parallel stents adjacent to the endograft main body to maintain perfusion to renal and/or visceral arteries and gain a suprarenal sealing zone using standard EVAR grafts.
An F-EVAR and subsequently a CG-EVAR programme have been established for JRAA since 2006 in our department.
A straightforward chimney technique protocol has been developed to treat patients with JRAA when the two main renal arteries (RAs) arise from the aorta at different crosssectional levels (discrepant; the lower margin of the upper renal artery is above the upper margin of the lower one) and the distance between the highest RA and the beginning of the aneurysm (improved landing zone) is !10 mm. To obtain an adequate proximal LZ, a standard endograft with suprarenal fixation struts is delivered with its proximal covered edge just below the highest RA, whereas the low-lying renal artery is maintained patent by an uncovered self-expanding stent (SES) called "Open Chimney" (OCh).
The aim of the present study is to report preoperative clinical and anatomical patient characteristics, operative data as well as perioperative, and follow-up results of the OCh technique.
MATERIALS AND METHODS

Patients and anatomical evaluation
From July 2010 to November 2012, OCh-EVAR was performed for JRAA in consecutive patients with discrepant RAs. The proximal LZ was relocated below the highest RA ( Fig. 1 ) and included the length of infrarenal neck (L1), the diameter of lowest RA (L2) and the distance between RAs (L3). The anatomical inclusion criteria were defined as L1 between 1 and 9 mm, LZ !10 mm and a regular, parallelshaped LZ with a diameter 32 mm. Contraindication to OCh-EVAR was a conical-shaped LZ with diameter increasing downward >2 mm, as well as with presence of thrombus and calcification.
All anatomical features were documented according to recommended standards with the exception of the aortic angle F, defined as the most acute angle in the pathway between the lowest renal artery and the aortic bifurcation. 7 Having relocated the proximal neck above the lowest RA, F was considered the most acute angle in the pathway between the highest RA and the aortic bifurcation.
Patients with JRAA and emergence of the two main RA at the same cross-sectional level were evaluated for F-or CG-EVAR using covered stents for both RAs.
Only high-risk patients with comorbidities prohibitive for open surgery were considered candidates for OCh-EVAR. These included patients with poorly compensated or recurrent congestive heart failure, ejection fraction 35%, severe aortic valve stenosis, myocardial infarction within 6 months, symptomatic or poorly controlled ectopy/ arrhythmia (chronic/recurrent), pulmonary dysfunction (forced expiratory volume in 1 second of 1 L) or requiring oxygen replacement therapy, and those with a hostile abdomen as a result of multiple prior abdominal surgeries. Patients were preoperatively evaluated by attending physicians, hospital anesthesiologists, and cardiologists when more accurate assessments were needed.
The study methodology and design were approved by the local university hospital board and written informed consent was obtained for all patients.
All patients underwent abdominal and thoracic CT scan examination and DICOM images were analysed on a PC workstation using Dx Care (Medasys, Gif-sur-Yvette, France) software Ver. 6.3e14. Thoracic CT scan images were evaluated for arch and left subclavian anatomy owing to chimney graft delivery.
All patients in this series underwent first-time repair of JRAA. No patients with ruptured or leaking JRAAs were treated with OCh-EVAR. No devices were modified or altered before implantation. Increased oversizing was not planned for OCh-EVAR compared with standard EVAR.
Procedural technique
All procedures were carried out by, or under the supervision of, the same vascular team, in a hybrid surgical room with a portable C-Arm Fluoroscope.
All patients underwent general anaesthesia. Through small (3e5 cm) longitudinal incisions, both femoral and the proximal left brachial arteries were surgically exposed. Systemic heparin sodium (5,000 units by intravenous injection) was given. Over a hydrophilic 0.035 guidewire, 9F 12 cm-long (Terumo Europe, Leuven, Belgium) sheaths were inserted into both common femoral arteries and a 5F 12 cm-long sheath (Terumo) into the left brachial artery.
From the left brachial access, a hydrophilic 0.035 guidewire was positioned in the distal descending thoracic aorta, the 5F sheath exchanged for a 6F, 65 cm-long sheath (Destination, Terumo) and through it, the lowest renal artery was targeted. Using a hydrophilic guidewire, a 5F vertebral catheter was inserted well into the lowest renal artery and a wire exchange was made for a superstiff 0.035 
Rosen wire (CookEurope, Bjaeverskov, Denmark). The aortic endograft main body was introduced from the selected femoral access and placed in the infrarenal aorta. Only endografts with suprarenal uncovered stents fixation were employed. An uncovered nitinol self-expanding stent (SES) of appropriate length and diameter was placed into the target vessel without releasing it. Under roadmap acquisition, the endograft was deployed with the proximal edge of the first covered stent just below the highest main RA, without completely releasing the proximal uncovered stents of the endograft. The previously positioned renal SES, was then opened to allow RA perfusion. SES was delivered 2 to 3 cm into the RA with its proximal end opening at the middle portion of the suprarenal uncovered endograft stents, which were finally completely released. Catheterisation of the contralateral endograft leg was then completed and iliac limbs delivered. The entire endograft was dilated using a compliant balloon, without any need for simultaneous SES ballooning. However, the guidewire was always left inside the stented renal artery for possible balloon dilatation after the final angiographic control. Completion angiography was performed to assess the correct endograft position, the absence of stent stenosis, RAs perfusion, and presence of any type of endoleak.
Postoperative management and data presentation
Double antiplatelet drugs (clopidogrel and aspirin) were given for at least 1 month, followed by lifelong single antiplatelet drug therapy.
Contrast CT scan control was performed before discharge, between 3 and 6 months postoperatively, and yearly thereafter. Non contrast-CT and Duplex scan were performed in patients with renal insufficiency. Clinical followup consisted of physical and laboratory examinations including serum creatinine at 1 month, 6 months, and yearly thereafter if no complications were observed. Additional clinical, laboratory, and Duplex-scan examinations were performed for all patients at the end of the present study for investigational purposes.
All clinical, anatomical, and operative data were prospectively collected in an expressly designed database and retrieved for the study analysis. Primary end points were technical success (successfully completed procedure with endograft patency, preservation of target vessels, and no evidence of type I or III endoleak at post-procedural imaging), 30-day mortality and morbidity. Follow-up was focused on allcause mortality, branch vessel patency, renal impairment, and secondary interventions. Because of the small number of patients, no control groups were selected for the study and data are presented in a descriptive analytic method. Categoric data are described using absolute numbers and percentage of prevalence (%) in the study cohort, whereas continuous variables are presented as median (range).
RESULTS
OCh-EVAR was offered to 22 consecutive patients (21 male) considered to be at excessive risk for open repair for JRAA.
Seventeen procedures were performed at the main study centre and the remaining five were performed at other European vascular surgery centres, where the same team was tutoring for complex endovascular aortic procedures. During the same period of time 84 patients with JRAA underwent F-(62 patients) or CG-EVAR (22 patients) using !2 covered stents. Four patients underwent urgent CG-EVAR for contained ruptured JRAAs.
Comorbidities typical of this high-risk cohort for AAA patients are presented in Table 1 .
Thirteen patients (59%) were American Society of Anesthesiologists class 3, five patients (23%) were class 4, and were felt to be unsuitable candidates for major open surgery by the in-hospital cardiologist and operative team. Four patients presented a hostile abdomen caused by multiple previous intra-abdominal surgeries.
Anatomical aneurysm characteristics are reported in Table 2 . The median aneurysm size was 58.5 mm (45e100). One patient was operated for a small (45 mm) rapidly enlarging saccular aneurysm. All patients were asymptomatic with a recently discovered JRAA. The median L1 (infrarenal neck length) of 4.5 mm (1e9) and D1 (diameter 15 mm below the lowest RA) of 40. All the procedures were technically successful with JRAA exclusion and patent chimney graft, except for the occurrence of one type Ia endoleak. Because of its small entity, it was decided not to treat the endoleak immediately. The 3-month CT control showed a complete regression of the endoleak. Four type II endoleaks were also detected at final angiography, one disappeared at the 6-month CT control. One accessory renal artery was present in five patients and occluded in two without renal function changes. Table 1 summarises perioperative outcomes as well as follow-up results regarding renal function and aneurysm sac evolution. The median length of the procedure was 105 minutes (75e290), blood loss 55 ml (30e550) and hospital stay 6.5 days (4e50).
Two major perioperative complications were observed. One patient died (4.5%) in the intensive care unit 4 hours after the procedure because of acute decompensated heart failure. The patient presented a history of recurrent congestive heart failure with an ejection fraction <30%. The patient had a complex procedure characterised by successful aneurysm exclusion with right renal artery OCh, yet immediately complicated by bilateral iliac leg thrombosis, probably caused by an underlying undetected coagulopathy and poor lower limb outflow. Several endograft thrombectomies and associated distal iliac and femoral bilateral angioplasties led to iliac leg patency with good distal outflow.
One patient presented an immediate post-procedural right hemiplegia. The following CT scan showed a hemispheric stroke in the left carotid artery territory. The patient underwent a rehab programme with a modest functional recovery and was discharged from hospital 50 days after the procedure.
Three patients presented postoperative complications. One patient had an acute onset of renal failure 3 days after the procedure. He had a previously well-known "shaggy" distal thoracic aorta and underwent a postoperative angio-CT scan control, showing multiple distal emboli in the territory of both renal and the splenic arteries with normal patency of the main branches as also indicated in the final procedural angiography. The patient was transferred to the nephrology division showing a significant improvement in renal function without requiring dialysis and with a moderate stable increase (>20%) in creatinine values (w2.5 mg/dL) during the follow-up and changed from Chronic Kidney Disease (CKD) stage 2 to stage 3b. Another patient had a progressive pain in the right gluteus starting the 1st postoperative day, which progressed into rhabdomyolysis and acute renal failure. The patient had a planned occlusion (coils and plug embolisation) of the right internal iliac artery because of a concomitant common iliac aneurysm.The patient was also treated conservatively without requiring dialysis with serum creatinine returning almost back to preoperative values during the follow-up, switching to CKD stage 3a to 3b, with a creatinine increase <20%. He suffered from a moderate right buttock claudication. The last patient presented an iliac leg occlusion at the CT control before discharge without symptoms and with an otherwise uneventful postoperative stay. The occlusion was caused by a kinking between the common and the external iliac artery following endograft positioning and was successfully treated by thrombectomy and uncovered stent delivery from the endograft leg to the first portion of the external iliac artery.
Follow-up CT and Duplex scans showed patency of all renal arteries without any sign of chimney stent or RA stenosis (Fig. 2) at the median follow-up of 18 months (range 7e35). No aneurysm has enlarged during the followup with a median sac regression for the entire cohort of 9 mm at latest follow-up. With the exception of the two patients presenting the renal function complications described above, no changes were observed of preoperative CKD stages and serum creatinine values, postoperatively and during the follow-up.
DISCUSSION
Since the first description of the GC technique as a bailout procedure 6 in 2003, this "off-label" technique has been improved and expanded by different authors 8e11 to restore flow in aortic branches accidentally or intentionally covered and to obtain an adequate sealing during TEVAR in the aortic arch, for patients with JRAAs and in urgent cases when offthe-shelf devices need to be employed. Many studies have been published on CG technique with relatively good perioperative and short-term results as described by Moulakakis et al. 11 in the metanalysis evaluating the results of 15 recent reports on the CG technique for JRAA.
The 30-day mortality of our series was 4.5%, similar to the mortality (4.3%) in the reported metanalysis. 11 The mortality for JRAA in our study is low considering 82% of the patient cohort were deemed class III and IV American Society of Anesthesiologists (ASA) and 76% presented severe cardiac disease. The deceased patient in our series presented a very poor cardiac status (ejection fraction <30).
Stroke complications are reported during CG-EVAR and could represent a limitation also in the OCh graft technique as in all endovascular techniques requiring a supra-aortic vessel access. In the same metanalysis, 11 Moulakakis described ischaemic stroke in 3.2% of patients. One patient in our series presented a perioperative ischaemic stroke in the territory of the left carotid artery. Ischaemic stroke in the left carotid cerebral area is unexpected during left brachial access and could also be explained by wire manipulation across the aortic arch from distal femoral accesses.
Additional 30-day complications were related to complex distal accesses (iliac artery tortuosity and aneurysm) in two patients and to a diseased proximal aorta in the other. In this last patient multiorgan embolisation (spleen and kidneys) could be explained by stiff guidewires and catheter manipulation coming from proximal as well as distal accesses across the "shaggy" thoracic aorta. The two observed postoperative acute renal failures are to be ascribed to such complications and not to chimney graft delivery.
Aneurysm exclusion and patent OCh graft were achieved in all patients. The median time of the procedure (105 minutes), estimated blood loss (55 mL), contrast medium (65 mL), and X-ray time exposure (23 minutes) demonstrate that OCh-EVAR is a straightforward technique for complex aortic aneurysm disease.
Patients included in the present study represent a subpopulation of patients presenting with JRAA. Indication to OCh-EVAR requires a discrepant origin of the two RAs in JRAA. In our experience, this anatomical condition occurred in 20% (22/106) of all JRAAs undergoing EVAR during the same period of time.
Because of the position of the aorta, the inferior vena cava, and the kidneys in the body, the origin of the two RAs at different cross-sectional levels from the aorta is a common anatomical condition. 12 In one study the right and left renal arteries were reported to be at the same level in only 30% of cases, whereas the right was higher in 47% and the left was higher in about 23% of cases. 13 There were no reported sex-(gender) or race-related differences.
Major limitations of the present study are the low number of treated patients and the relatively short followup time. However, among published series on CH-EVAR, the present series is one of the largest and with the longest follow-up. 11 Another clear limitation of the present study is that this is neither a randomised, nor even a controlled trial with any comparisons, and results should be interpreted cautiously. The small number of expected patients (high physiological risk in selected JRAA anatomies) would have made any statistically significant conclusion difficult to reach with any possible control group.
An alternative endovascular approach to JRAA in our series was the F-EVAR. A single-fenestration configuration is rarely used in F-EVAR. According to manufacturer instructions for ordering (Zenith Fenestrated, Cook), F-endograft engineering requires a distance !15 mm between a small fenestration and the proximal edge of the graft. Such condition (distance between the two RAs !15 mm) was present only in one patient of our series (Table 2) . Therefore, in 95.5% of our series, two fenestrations and most probably a scallop would have been requested to manufacture a fenestrated endograft. Moreover, the tortuosity of the aorta in our series (median F angle: 125 ) would have potentially made F-EVAR more difficult than OCh-EVAR. In F-EVAR, one or two fenestrations with or without a scallop in the partially opened Fendograft should be aligned with the corresponding target vessels along the angled neck, whereas in OCh-EVAR, one renal artery is targeted before the endograft is positioned into the aorta. Therefore, besides the time required for the customisation, complexity of the procedure, X-ray exposure, and costs would have undoubtedly increased with F-EVAR.
Covered stent grafts are usually employed in CG-EVAR. 14, 15 However, uncovered CG have been used and described by other authors. The ideal characteristics of the renal artery stent (covered vs. uncovered, self-expanding vs. balloonexpandable) for use in the CG procedure have not yet been clarified. Hiramoto et al. 16 successfully used uncovered stents, not only as bailout techniques to rescue a renal artery but also in planned procedures to increase the proximal landing zone in selected cases (eight patients). The authors also performed CG-EVAR, using a single uncovered graft for one low-lying renal artery. We have systematically used the OCh-technique when the previously described anatomical criteria in JRAA were encountered, offering this procedure to 22 consecutive patients. We agree with Hiramoto et al. that the covered nature of the stent does not confer any advantage in renal patency nor any protection against a type I endoleak, provided that some amount of suitable "infrarenal" neck is present. In our opinion, an uncovered stent allows a higher renal blood flow through the "physiological" gutter ( Fig. 3) and open stent struts possibly conferring an advantage in the long-term patency. Unlike Hiramoto et al., our preference is for the new generation of self-expanding stents because of their flexibility, stability during release (antijumping mechanisms), and the reduced size of the delivery system (up to 4F in the Astron18, Biotronic).
When the two RAs origin at the same level in JRAA, we prefer a F-technique or GG-strategy using covered stent grafts. Two or more chimney grafts displace the endograft fabric further from the aortic wall increasing the risk of type Ia endoleak and therefore a longer sealing zone may be required and uncovered stents may not be adequate.
In our series, a small type I endoleak was observed only in one patient (4.5%) and disappeared at the 3-month CT scan control, without any evidence of new endoleaks at the median follow-up of 18 months.
Conclusions
The results of the present study show that the OCh-EVAR is a straightforward technique that can be employed in selected cases of JRAA with discrepant renal arteries. In such anatomical conditions, OCh-EVAR has the advantages of reducing the complexity, manufacturing time, and costs of F-EVAR. Compared with covered stents, SES requires a smaller and more flexible delivery system, potentially reducing complications from left brachial access. The median 18-month follow-up results of this technique are very encouraging without any type I and III endoleaks, CG stenosis or renal function deterioration, although longer-term follow-up is awaited to establish the durability of this approach. 
